Rupert Vessey
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Herpesvirus Infections and Treatments, T-cell and B-cell Immunology, Respiratory Support and Mechanisms
Most-Cited Works
- → Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease(2006)459 cited
- → Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine(2000)363 cited
- → Lung eQTLs to Help Reveal the Molecular Underpinnings of Asthma(2012)329 cited
- → Profiling serum biomarkers in patients with COPD: associations with clinical parameters(2007)204 cited
- → Influence of Age and Nature of Primary Infection on Varicella‐Zoster Virus–Specific Cell‐Mediated Immune Responses(2010)118 cited
- → C-reactive protein in patients with COPD, control smokers and non-smokers(2006)97 cited
- → Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression(2000)91 cited
- → Antigen Burden Is a Major Determinant of Human Immunodeficiency Virus–Specific CD8+T Cell Maturation State: Potential Implications for Therapeutic Immunization(2003)64 cited
- → Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?(2008)61 cited
- → Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age(2011)59 cited